Purpose:
To investigate the clinical value of real-time three-dimensional contrast-enhanced ultrasound (3D-CEUS) in the detection of sentinel lymph nodes (SLNs) and drainage lymphatics in breast cancer patients.
Method:
The prospective study was performed in women with pathology-confirmed T1/2 breast cancer between June 2016 and December 2017 who underwent sentinel lymph node biopsy and 3D-CEUS. The number, size, location, enhancement pattern of SLNs, and the lymphatic drainage patterns were reviewed. The routes, location of SLNs, and lymph channels (LCs) on the surface were marked. All patients underwent blue dye-guided sentinel lymph node biopsy (SLNB) finally.
Results:
According to the postoperative pathology findings and the blue dye staining of the lymphatic drainage routes, there are six patterns of lymphatic drainage routes and the coincidence rate of the 3D-CEUS was 97.4%; the sensitivity, specificity, positive predictive value, negative predictive value, the LN detection rate, and the correct diagnosis rate of the 3D-CEUS were 75%, 93.0%, 81.8%, 89.9%, 95.3%, and 87.7%, respectively.
Conclusion:
3D-CEUS is a new feasible and useful approach to detect the SLNs and LCs. 3D-CEUS can accurately localize the LCs and SLNs and estimate the presence of metastatic lymph nodes.
Key Points:
• The three-dimensional contrast-enhanced ultrasound can detect the sentinel lymph nodes. • The three-dimensional contrast-enhanced ultrasound can show the stereo direction of sentinel lymph nodes and lymph drainage routes. • The three-dimensional contrast-enhanced ultrasound can accurately localize the LCs and SLNs and estimate the presence of metastatic lymph nodes.
Citing Articles
Artificial intelligence in fracture detection on radiographs: a literature review.
Lo Mastro A, Grassi E, Berritto D, Russo A, Reginelli A, Guerra E
Jpn J Radiol. 2024; .
PMID: 39538068
DOI: 10.1007/s11604-024-01702-4.
The value of the improved percutaneous and intravenous contrast-enhanced ultrasound diagnostic classification in sentinel lymph nodes of breast cancer.
Huang C, Luo J, Shan Z, Zhen T, Li J, Ma Q
Quant Imaging Med Surg. 2024; 14(3):2391-2404.
PMID: 38545047
PMC: 10963847.
DOI: 10.21037/qims-23-1210.
Association and predictive value of contrast‑enhanced ultrasound features with axillary lymph node metastasis in primary breast cancer.
Kuang X, Lin L, Yuan H, Zhao L, He T
Oncol Lett. 2024; 27(3):98.
PMID: 38298429
PMC: 10829074.
DOI: 10.3892/ol.2024.14231.
Predicting axillary metastasis in breast cancer using lymphatic contrast-enhanced ultrasound-guided fine-needle aspiration of one lymph node.
Zhuang L, Liu J, Xu X, Sun X, Li F, Shi Q
Br J Radiol. 2024; 97(1154):363-370.
PMID: 38265292
PMC: 11027278.
DOI: 10.1093/bjr/tqad054.
Advantages of contrast-enhanced ultrasound in the localization and diagnostics of sentinel lymph nodes in breast cancer.
Yang Q, Fu Y, Wang J, Yang H, Zhang X
J Zhejiang Univ Sci B. 2023; 24(11):985-997.
PMID: 37961801
PMC: 10646391.
DOI: 10.1631/jzus.B2300019.
Use of machine learning with two-dimensional synthetic mammography for axillary lymph node metastasis prediction in breast cancer: a preliminary study.
Haraguchi T, Goto Y, Furuya Y, Nagai M, Kanemaki Y, Tsugawa K
Transl Cancer Res. 2023; 12(5):1232-1240.
PMID: 37304551
PMC: 10248572.
DOI: 10.21037/tcr-22-2668.
Diagnosing sentinel lymph node metastasis of T1/T2 breast cancer with conventional ultrasound combined with double contrast-enhanced ultrasound: a preliminary study.
Zheng Y, Sun J, Zhu L, Hu M, Hou L, Liu J
Quant Imaging Med Surg. 2023; 13(6):3451-3463.
PMID: 37284112
PMC: 10239995.
DOI: 10.21037/qims-22-1175.
Ultrasound contrast-enhanced patterns of sentinel lymph nodes: predictive value for nodal status and metastatic burden in early breast cancer.
Zhu Y, Jia Y, Pang W, Duan Y, Chen K, Nie F
Quant Imaging Med Surg. 2023; 13(1):160-170.
PMID: 36620166
PMC: 9816714.
DOI: 10.21037/qims-22-234.
Optimal Selection of Imaging Examination for Lymph Node Detection of Breast Cancer With Different Molecular Subtypes.
Zheng M, Huang Y, Peng J, Xia Y, Cui Y, Han X
Front Oncol. 2022; 12:762906.
PMID: 35912264
PMC: 9326026.
DOI: 10.3389/fonc.2022.762906.
The value of preoperative sentinel lymph node contrast-enhanced ultrasound for breast cancer: a large, multicenter trial.
Li J, Li H, Guan L, Lu Y, Zhan W, Dong Y
BMC Cancer. 2022; 22(1):455.
PMID: 35473499
PMC: 9040273.
DOI: 10.1186/s12885-022-09551-y.
The value of contrast-enhanced ultrasound enhancement patterns for the diagnosis of sentinel lymph node status in breast cancer: systematic review and meta-analysis.
Niu Z, Xiao M, Ma L, Qin J, Li W, Zhang J
Quant Imaging Med Surg. 2022; 12(2):936-948.
PMID: 35111595
PMC: 8739145.
DOI: 10.21037/qims-21-416.
Contrast-Enhanced Ultrasound for Precise Sentinel Lymph Node Biopsy in Women with Early Breast Cancer: A Preliminary Study.
Zhu Y, Fan X, Yang D, Dong T, Jia Y, Nie F
Diagnostics (Basel). 2021; 11(11).
PMID: 34829452
PMC: 8624576.
DOI: 10.3390/diagnostics11112104.
Prediction of Metastasis in the Axillary Lymph Nodes of Patients With Breast Cancer: A Radiomics Method Based on Contrast-Enhanced Computed Tomography.
Yang C, Dong J, Liu Z, Guo Q, Nie Y, Huang D
Front Oncol. 2021; 11:726240.
PMID: 34616678
PMC: 8488257.
DOI: 10.3389/fonc.2021.726240.
Contrast-Enhanced Ultrasonography in the Diagnosis and Treatment Modulation of Breast Cancer.
Boca Bene I, Dudea S, Ciurea A
J Pers Med. 2021; 11(2).
PMID: 33573122
PMC: 7912589.
DOI: 10.3390/jpm11020081.